Myths and Misconceptions of Medication-Assisted Treatment
This web page discusses the myths and misconceptions of medication-assisted treatment for individuals with a substance use disorder.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
This web page discusses the myths and misconceptions of medication-assisted treatment for individuals with a substance use disorder.
This document has been reproduced with permission from Boston Medical Center(c) and is excerpted from: LaBelle, C. T.; Bergeron, L. P.; Wason, K.W.; and Ventura, A. S. Policy and Procedure Manual of the Office Based Addiction Treatment Program for the use of Buprenorphine and Naltrexone Formulations in the Treatment of Substance Use Disorders. Unpublished treatment manual, Boston Medical Center, 2016.
Assists primary care providers in determining if an opioid taper is necessary for a specific patient, in performing the taper, and in providing followup and support during the taper.
This is a fact sheet for the OpiSafe website, which provides support for opioid prescribers by performing risk stratification for each patient on the basis of morphine-equivalent dosing ranges, pain and function scores, opioid misuse risk scores, and automated prescription drug monitoring program checks.
Looks at various barriers to accessing mental health and substance use disorder treatment and services in rural communities and describes how telehealth interventions may provide ways to overcome specific barriers